NLRP3 and metabolic syndrome: Moreover, the activation of purinergic 2X7 receptors (P2X7R) in conjunction with the NLRP3 inflammasome has been identified as a significant contributor to renal inflammation and injury within the context of metabolic syndrome-related renal ailments.